AI Portfolio Summary
In 2025 Q4, Checkpoint Capital L.P. maintained a portfolio of 11 distinct positions. The most significant new addition to the portfolio was CORCEPT THERAPEUTICS, which now represents 1.39% of the total fund value. They heavily accumulated shares in RHYTHM PHARMACEUTICA, increasing their position by 29.9%. Conversely, Checkpoint Capital L.P. completely exited their position in KYMERA THERAPEUTICS .
Total Positions
11
Quarter
2025 Q4
Top Holding
ARGX (37.3%)
Top 10 Concentration
100.0%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
Showing 1-11 of 11
| Stock | History | Sector / Type | Port % | Prev % | Rank / Prev | Conviction | Change | % Change | Influence | Shares | Mkt Value | Avg Cost | Price Held | 1st Owned | Source | Source Date | Date Reported |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
ARGX
ARGENX SE
|
Healthcare | 37.31% | 37.07% |
#1
Prev: #1
|
6.5 | -8,000 | -5.3% |
P
S
|
142,000 | $119,414,900 |
$464.29
+72.5%
|
2023 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | ||
|
RYTM
RHYTHM PHARMACE...
|
Healthcare | 33.18% | 25.84% |
#2
Prev: #2
|
8.0 | 228,493 | 29.9% |
P
S
|
992,200 | $106,205,088 |
$57.45
+77.3%
|
2023 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | ||
|
IRON
DISC MEDICINE I...
|
Healthcare | 11.24% | 9.52% |
#3
1
Prev: #4
|
7.0 | 22,992 | 5.3% |
P
S
|
452,992 | $35,972,095 |
$62.30
+26.9%
|
2023 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | ||
|
RVMD
REVOLUTION MEDI...
|
Healthcare | 9.21% | 7.70% |
#4
1
Prev: #5
|
4.2 | -122,300 | -24.8% |
P
S
|
370,000 | $29,470,500 | 2024 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
CORT
CORCEPT THERAPE...
|
Healthcare | 4.36% | 10.92% |
#5
2
Prev: #3
|
2.7 | 9,064 | 2.3% |
P
S
|
401,395 | $13,968,546 | 2024 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
CYTK
CYTOKINETICS IN...
|
Healthcare | 3.31% | 0.69% |
#6
4
Prev: #10
|
4.3 | 129,236 | 343.8% |
P
S
|
166,823 | $10,599,933 | 2023 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
CORT
CALL
CORCEPT THERAPE...
|
CALL Option | 1.39% | — |
#7
Prev: #—
|
4.1 | 128,300 | no change |
NEW
|
128,300 | $4,464,840 | 2024 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
KYMR
KYMERA THERAPEU...
|
Healthcare | 0.00% | 1.17% |
Sold All 😨
(Was: #9) |
0.0 | -61,750 | -100.0% |
CLOSED
|
— | $— | 2024 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
STOK
STOKE THERAPEUT...
|
Healthcare | 0.00% | 1.67% |
Sold All 😨
(Was: #8) |
0.0 | -212,049 | -100.0% |
CLOSED
|
— | $— | 2024 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
SEPN
SEPTERNA INC
|
Healthcare | 0.00% | 1.78% |
Sold All 😨
(Was: #7) |
0.0 | -283,158 | -100.0% |
CLOSED
|
— | $— | 2025 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
CRNX
CRINETICS PHARM...
|
Healthcare | 0.00% | 3.63% |
Sold All 😨
(Was: #6) |
0.0 | -260,000 | -100.0% |
CLOSED
|
— | $— | 2025 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) |
Showing 1-11 of 11 holdings